Latest News

This clinical-stage biotech develops antibody therapies for cancer and infectious diseases, leveraging proprietary discovery platforms.
Via The Motley Fool · February 22, 2026
It's about striking that perfect balance between chasing growth and protecting what you already have.
Via The Motley Fool · February 22, 2026

This clinical-stage biotech develops targeted cancer therapies, leveraging bispecific antibodies and strategic industry partnerships.
Via The Motley Fool · February 22, 2026
Via Talk Markets · February 22, 2026
Via Talk Markets · February 22, 2026
Via Talk Markets · February 22, 2026
Vertiv has seen incredibly strong demand from data center operators for its cooling and power solutions.
Via The Motley Fool · February 22, 2026

Krystal Biotech develops redosable gene therapies targeting rare skin diseases, with a late-stage clinical pipeline and expanding portfolio.
Via The Motley Fool · February 22, 2026

Scholar Rock develops therapies for neuromuscular and oncological diseases, leveraging a proprietary platform to target unmet medical needs.
Via The Motley Fool · February 22, 2026
Via Talk Markets · February 22, 2026
The company's years of beating the market aren't over yet.
Via The Motley Fool · February 22, 2026

This diversified utility delivers natural gas, electric, and propane services to customers across the eastern U.S.
Via The Motley Fool · February 22, 2026
Cleveland may sound like a sleepy little midwestern town. However, it's anything but sleepy.
Via The Motley Fool · February 22, 2026
This latest purchase offers Druckenmiller another AI winner.
Via The Motley Fool · February 22, 2026
Will the tech giant be able to follow through on its aspirations?
Via The Motley Fool · February 22, 2026

SSR Mining is a global precious metals producer with operations spanning gold, silver, and base metals across four continents.
Via The Motley Fool · February 22, 2026
With high-occupancy and long-term lease terms, this REIT is built for stability. But, is it still a buy?
Via The Motley Fool · February 22, 2026
The Direxion Daily Financial Bear 3X Shares is still useful for some traders, but don't expect it to act like 2008 is back.
Via The Motley Fool · February 22, 2026
Bill Ackman just bet big on Meta Platforms.
Via The Motley Fool · February 22, 2026
It's time for investors to think about the progression of autonomous vehicle technology.
Via The Motley Fool · February 22, 2026
Palo Alto's business is going from strength to strength as it prepares customers for an increasingly dangerous cyber landscape.
Via The Motley Fool · February 22, 2026
The stock is falling, but that creates opportunity.
Via The Motley Fool · February 22, 2026

Shanghai-based Nio designs and sells smart electric vehicles, leveraging proprietary battery swapping and integrated service solutions.
Via The Motley Fool · February 22, 2026
Merck has an attractive yield and a long history of dividend growth.
Via The Motley Fool · February 22, 2026